Commentary

Video

Challenges With CAR T-Cell Therapies in T-Cell Lymphomas

Author(s):

Jasmine Zain, MD

In Partnership With:

Jasmine M. Zain, MD, of City of Hope, discuss challenges in CAR-T therapies in patients with T-cell lymphomas.

Jasmine M. Zain, MD, of City of Hope, discuss challenges in CAR-T therapies in patients with T-cell lymphomas.

Related Videos
Grzegorz S. Nowakowski, MD
Alexey Danilov, MD, PhD
A panel of 3 experts on nasopharyngeal carcinoma
Alexey Danilov, MD, PhD
A panel of 3 experts on nasopharyngeal carcinoma
Grzegorz S. Nowakowski, MD
Grzegorz S. Nowakowski, MD
Reid Merryman, MD
Partow Kebriaei, MD
A panel of 5 experts on CLL
Related Content
Radhika Bansal, MBBS, postdoctoral fellow, Mayo Clinic
September 9th 2024

Real-World Outpatient CAR T-Cell Administration Insights Show Improved Safety and Feasibility in NHL

Ravi Salgia, MD, PhD, professor, chair, Department of Medical Oncology & Therapeutics Research, Arthur & Rosalie Kaplan Chair in Medical Oncology & Therapeutics Research, City of Hope
September 2nd 2024

Salgia Summarizes the Benefits of Tepotinib in MET Exon 14–Mutated NSCLC

Jason R. Westin, MD, of The University of Texas MD Anderson Cancer Center
September 7th 2024

Frontline Golcadomide/R-CHOP Combo Elicits Antitumor Activity in Aggressive B-Cell Lymphoma

Oncology Unplugged
August 21st 2024

Park and Kasi Expand on Perioperative Immunotherapy Updates in CRC

Neha Mehta-Shah, MD, MSCI, assistant professor, Washington University
September 7th 2024

Histologic Distinctions and Optimized Imaging Carve New Paths for Individualized PTCL Management

Non-Hodgkin Lymphoma | Image Credit: © freshidea - stock.adobe.com
September 6th 2024

Subcutaneous Rituximab Remains Underutilized in Non-Hodgkin Lymphoma